(Q62083142)
Statements
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study (English)
S Bonavita
G Ventrella
G Vacca
A Prinster
23 November 2011
scientific article published on 23 November 2011